The Small Molecule P7C3-A20 Exerts Neuroprotective Effects in a Hypoxic–ischemic Encephalopathy Model via Activation of PI3K/AKT/GSK3β Signaling
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 441, 197-208
Abstract
No abstract availableKeywords
Funding Information
- Beijing Medical and Health Foundation (B17137)
- National Natural Science Foundation of China (81771624)
- Wenzhou Municipal Science and Technology Bureau (Y20190001)
This publication has 38 references indexed in Scilit:
- P7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD SalvageCell, 2014
- P7C3 and an unbiased approach to drug discovery for neurodegenerative diseasesChemical Society Reviews, 2014
- In vitro regulation of hepatocellular carcinoma cell viability, apoptosis, invasion, and AEG-1 expression by LY294002Clinics and Research in Hepatology and Gastroenterology, 2014
- Enhanced Phosphatidylinositol 3-kinase (PI3K)/Akt Signaling Has Pleiotropic Targets in Hippocampal Neurons Exposed to Iron-induced Oxidative StressJournal of Biological Chemistry, 2013
- Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2012
- Neuronal cell death in neonatal hypoxia‐ischemiaAnnals of Neurology, 2011
- Development of Proneurogenic, Neuroprotective Small MoleculesJournal of the American Chemical Society, 2011
- Brain damage related to hemorrhagic transformation following cerebral ischemia and the role of KATP channelsBrain Research, 2008
- Hypothermia: A Neuroprotective Therapy for Neonatal Hypoxic-Ischemic EncephalopathyPediatrics, 2006
- ‘Ischemic tolerance’ phenomenon detected in various brain regionsBrain Research, 1991